Table 2.
Demographic and clinical data (mean ± SD)
| study group | control group | t/χ2value | P | |
|---|---|---|---|---|
| (n = 39) | (n = 41) | |||
| Demographics | ||||
| Gender (M/F) | 13/26 | 12/29 | 0.15 | 0.70 |
| Age (year) | 15.3 ± 2.5 | 14.9 ± 2.4 | 0.73 | 0.47 |
| Education (year) | 7.2 ± 2.3 | 7.1 ± 2.2 | 0.20 | 0.84 |
| Clinical characteristics | ||||
| Mean episode duration(year) | 0.7 ± 1.8 | 0.6 ± 2.0 | 0.23 | 0.82 |
| ASLEC | 41.5 ± 10.3 | 39.9 ± 11.2 | 0.66 | 0.51 |
| IES-R | 19.6 ± 3.6 | 18.9 ± 4.4 | 0.78 | 0.44 |
| HAMD-17 | 22.3 ± 3.9 | 21.8 ± 3.6 | 0.60 | 0.55 |
| HAMA | 18.8 ± 3.4 | 19.7 ± 4.3 | 1.04 | 0.30 |
| Medication | ||||
| Escitalopram (mg/qd) | 13.4 ± 3.5 | 14.1 ± 3.7 | 0.87 | 0.39 |
Note ASLEC: Adolescent Self-Rating Life Events Checklist; IES-R: Impact of Event Scale-Revised; HAMD-17: 17-item Hamilton Depression Scale; HAMA: Hamilton Scale